Support our sponsors:

NZX 50 Index	3324.67	9.50
S&P/ASX 200	4289.40	15.20
Dow Jones Industrials	12878.20	33.10

Twitter

Facebook

RSS

F&P Healthcare stocks drops as profit forecast misses estimates

Tuesday 26th May 2009

Text too small?

Fisher & Paykel Healthcare shares tumbled after the manufacturer of breathing masks and respirators forecast 2010 earnings that were lower than analysts had expected.

The shares declined 5.5% to $2.90, the lowest in more than a month. Earnings are forecast to rise to $75 million to $80 million this year on operating revenue of $540 million, assuming the kiwi averages about 60 U.S. cents, the company said today. That’s less than the $102.9 million estimate in a Reuters survey.

The manufacturer, which competes in the health-care products market with ResMed and Respironics, today posted a 76% jump in full-year profit as the weaker New Zealand dollar swelled the value of rising sales of respirators and breathing masks in the U.S.

“The business is going fine but there’s just a question mark on the confusing outlook,” said Stephen Walker, investment strategist at Goldman Sachs JBWere. The forecast is “short of expectations.”

Net income rose to $62.2 million, or 11.8 cents a share, from $35.3 million, or 6.7 cents a year earlier, the Auckland-based company said in a statement today. Sales jumped 28% to $458.7 million, or 10.2% in U.S. dollar terms. Profit about matched the $61.8 million estimate in a Reuters survey.

“Demand for our respiratory humidifier systems was exceptionally strong,” said chief executive Mike Daniell. “Demand continued to be robust in the second-half.”

The company plans to establish an offshore manufacturing plant this year and roll out sales and distribution centres in four countries including Japan, he said

F&P Healthcare gets about 80% of its revenue in U.S. dollars. In the 2008 business year, the currency peaked at more than 81 U.S. cents and only briefly traded below 70 cents while the currency spent the second half of the latest year at 62 cents or below. The company will pay a final dividend of 7 cents a share, unchanged from a year earlier.

Daniell said respirator sales were helped by hospital Group Purchasing Organisation orders in the U.S. and deliveries of back orders in the first half of the year.

Businesswire.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.